Miotics and the Pharmacology of Pupil Testing

What a miotic is — and the muscle it pulls

The pupil is a ring of muscle wired to both halves of the autonomic nervous system. Two muscles set the size of the pupil. The sphincter pupillae — a circular band around the pupil margin — is driven by the parasympathetic system: acetylcholine acting on muscarinic (M3) receptors makes it contract, and the pupil shrinks (miosis). The dilator pupillae — radial fibres — is driven by the sympathetic system through alpha-1 receptors, pulling the pupil open (mydriasis). A miotic, then, is any drug that constricts the pupil, and the classic way to do it is to push the parasympathetic side: give a cholinergic agonist and drive the sphincter. This is simply the ocular face of the Autonomic Nervous System chapter — the same muscarinic pharmacology you meet in the gut and bladder, read here through a two-millimetre ring of iris.

The cholinergic miotics: direct and indirect

There are two ways to raise cholinergic tone at the sphincter: mimic acetylcholine, or stop it being broken down. The direct-acting miotics are muscarinic agonists — they bind the M3 receptor themselves. Pilocarpine is the archetype: a plant alkaloid that constricts the pupil and, by pulling on the ciliary body, opens the eye's drainage angle to lower pressure. Carbachol is a stronger, longer relative, resistant to breakdown, used topically and inside the eye at surgery. The indirect-acting miotics are anticholinesterases — they block acetylcholinesterase so the acetylcholine the eye releases is not destroyed and piles up at the receptor. Echothiophate is the historical example: an irreversible organophosphate that gives intense, prolonged miosis. Both routes end at the same place — more muscarinic signalling, a contracted sphincter, a small pupil — which is exactly the mechanism taught in the cholinergic-agonist and anticholinesterase sections of the Autonomic Nervous System chapter.

Uses beyond glaucoma

Miotics are best known for glaucoma — pilocarpine famously opens the angle and, in acute angle-closure, helps pull the iris out of the blocked angle as part of the emergency. But their reach is wider. They reverse pharmacological dilation: after a dilated fundus exam, a drop of pilocarpine can hurry the pupil back to size (though a dilating drug of the anticholinergic class won't budge — more on that below). At surgery, a surgeon wanting an instantly small pupil — say to protect the lens or after implanting an intraocular lens — injects a cholinergic agonist directly into the anterior chamber: intracameral acetylcholine (Miochol) or carbachol produces rapid, controlled miosis on the operating table. And the newest use is the most quietly clever: low-dose pilocarpine drops for presbyopia. Constricting the pupil turns it into a pinhole, and a pinhole increases the depth of focus — the same optics that let a squinting eye read fine print — so a middle-aged patient regains some near vision without reading glasses.

The elegant part: pupils as a diagnostic instrument

Two principles turn drops into a lie detector for nerves: denervation supersensitivity and receptor blockade. When a muscle loses its nerve supply, it doesn't just go quiet — it up-regulates its receptors, becoming super-sensitive to the very transmitter it no longer receives. This denervation (or disuse) supersensitivity is a general principle of pharmacology, taught in the receptor-regulation section of Principles of Pharmacology, and the iris shows it beautifully. A denervated sphincter or dilator will respond to a dose of agonist so dilute that a normally-innervated pupil barely notices. Add the mirror-image trick — a drop that blocks a receptor and asks whether the nerve behind it is intact — and you have a complete toolkit for localising, drop by drop, exactly where an autonomic lesion sits.

Testing a suspected Horner's syndrome

Horner's syndrome is a lesion of the sympathetic pathway to the eye — the three-neuron chain that runs from the hypothalamus, down into the chest, up around the carotid and into the orbit. Lose it and the dilator is unopposed no more: the pupil is small (miosis), the lid droops slightly (ptosis), and the face may not sweat (anhidrosis). The classic confirmatory drop was cocaine, which blocks noradrenaline reuptake: a normal pupil dilates because there is noradrenaline in the cleft to accumulate, but a Horner's pupil — with little or no noradrenaline being released — fails to dilate. The modern replacement is topical apraclonidine, an alpha agonist. It exploits denervation supersensitivity: the sympathetically-denervated dilator has up-regulated its alpha receptors, so apraclonidine dilates the affected pupil while barely touching the normal one — producing the striking reversal of anisocoria seen in the scene above. Then, to localise the lesion, hydroxyamphetamine (which releases noradrenaline from intact nerve terminals) separates a post-ganglionic (third-neuron) lesion — which fails to dilate, because the terminal is dead and has no stores to release — from a pre-ganglionic one, where the intact third neuron still dilates. This is the pupil-testing logic developed in full in the Neuro-ophthalmology chapter, and it rests entirely on the sympathetic anatomy from the Autonomic Nervous System chapter.

The tonic (Adie's) pupil and dilute pilocarpine

Now the parasympathetic mirror image. A tonic (Adie's) pupil comes from damage to the ciliary ganglion — the parasympathetic relay for the sphincter. The pupil is dilated, reacts poorly to light, and constricts slowly and "tonically" to a near target. Because the sphincter has lost its cholinergic supply, it has done exactly what denervated muscle does: up-regulated its muscarinic receptors. So a drop of dilute (low-concentration, e.g. 0.1%) pilocarpine — far too weak to constrict a normal sphincter — makes the tonic pupil constrict. A normal pupil in the other eye barely changes. The asymmetry is the diagnosis: the affected pupil, super-sensitive, constricts; the healthy one shrugs. It is denervation supersensitivity read directly off the iris, and it turns a confusing dilated pupil into a two-minute bedside answer.

The fixed dilated pupil: nerve palsy or a drop of atropine?

A large, unreactive pupil frightens everyone — but the drops tell you whether to. A widely dilated, non-reacting pupil can be an ominous third-nerve palsy (a compressive lesion pressing on the parasympathetic fibres — a surgical emergency) or something entirely benign: pharmacological mydriasis, where an anticholinergic drug has reached the eye and is blocking the muscarinic receptors on the sphincter. This is the mirror image of the Mydriatics chapter — the same atropine-class blockade used deliberately to dilate for examination, arriving here by accident. The test is the same dilute pilocarpine, but now the logic runs the other way. In a third-nerve palsy the sphincter's receptors are intact and hungry, so even a modest concentration of pilocarpine (usually 1%) will constrict the pupil. In atropinic mydriasis the receptors are pharmacologically blocked, so pilocarpine cannot constrict the pupil at all — the drug simply can't get a grip. A fixed dilated pupil that refuses to constrict to pilocarpine points away from a dangerous nerve palsy and toward the classic question every clinician learns to ask: "could this patient have got atropine — or a scopolamine patch, or a nebulised anticholinergic, or a plant alkaloid — into the eye?"